期刊文献+

血管紧张素转换酶抑制药联合血管紧张素Ⅱ受体阻断药治疗继发性局灶节段性肾小球硬化症患者的用药分析

Angiotensin converting enzyme inhibitor combined with angiotensin Ⅱ receptor blockers in the treatment of secondary focal segmental glomerular sclerosis in patients with drug use analysis
收藏 分享 导出
摘要 目的探讨临床药师在血管紧张素转换酶抑制药(ACEI)联合血管紧张素Ⅱ受体阻断药(ARB)治疗继发性局灶节段性硬化症中发挥的作用。方法临床药师参与1例ACEI联合ARB治疗继发性局灶节段性肾小球硬化症患者的临床治疗过程,确认治疗方案合理性并密切监测治疗过程中患者各项实验室指标及临床症状的变化,协助医师调整药物治疗方案。结果与结论临床药师参与个体化治疗方案调整并实施药学监护,有效减少了药物不良反应给患者带来的损害,在临床治疗过程中充分发挥了临床药师的作用。 Objective To explore the role of clinical pharmacists in the treatment of secondary focal segmental sclerosis with angiotensin converting enzyme inhibitors(ACEI)combined with angiotensinⅡreceptor blockers(ARB).Methods The clinical pharmacist participated in the clinical treatment process of a patient with secondary focal segmental glomerulus sclerosis treated by ACEI combined with ARB,confirmed the rationality of the treatment program,and closely monitored the changes of various laboratory indicators and clinical symptoms during the treatment process,and assisted the physician in adjusting the drug treatment program.Results and conclusion The clinical pharmacist participated in the adjustment of individualized treatment program and the implementation of pharmaceutical care,which effectively reduced the damage caused by adverse drug reactions to patients,and fully played the role of clinical pharmacist in the clinical treatment process.
作者 张利利 马凌云 陈超阳 梁雁 袁海龙 周颖 崔一民 ZHANG Li-li;MA Ling-yun;CHEN Chao-yang;LIANG Yang;YUAN Hai-long;ZHOU Ying;CUI Yi-ming(Department of Pharmacy,Peking University First Hospital,Beijing 100034,China;Department of Pharmacy,Air Force Special Medical Center,Beijing 100142,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2019年第7期701-702,705共3页 The Chinese Journal of Clinical Pharmacology
关键词 血管紧张素转换酶抑制药 血管紧张素Ⅱ受体阻断药 保肝药 局灶节段硬化 药学监护 angiotensin converting enzyme inhibitors angiotensinⅡreceptor blocker hepatic protector focal segment hardening pharmaceutical care
作者简介 张利利(1985-),女,药师,主要从事临床药学的相关工作;通信作者:周颖,主任药师,硕士生导师Tel:(010)66110802 E-mail:zhouying0321@126.com
  • 相关文献

参考文献3

二级参考文献51

  • 1姚勇,刘景城,肖慧捷,黄健萍,杨霁云.儿童新月体性IgA肾病临床与病理分析[J].临床儿科杂志,2004,22(12):783-787. 被引量:6
  • 233所医院儿童原发性IgA肾病临床和病理表现调查分析[J].中华儿科杂志,2007,45(4):272-278. 被引量:34
  • 3Mendoza SA, Reznik VM,Griswold WR, et al. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methyprednisolone and alkylating agents[J]. Pediatr Nephrol, 1990, 4:303-307. 被引量:1
  • 4Waldo FB, Benfield MR, Kohaut EC. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone[J]. Pediatr Nephrol, 1998, 12:397-400. 被引量:1
  • 5Brady HR, Wilcox CS. Therapy in Nephrology and Hypertension. A companion to Brenner and Rector'The Kidney[J]. Philadelphia:W.B. Saunders Company, 1999, 178-188. 被引量:1
  • 6Ponticelli C, Passerini P. Alternative treatments for focal and segmental glomerular sclerosis[J]. Clinical Nephrology ,2001,55:345-348. 被引量:1
  • 7Benchimol C. Focal segmental glomerulosclerosis: pathogenesis ang treatment[J]. Current Opinion in Pediatrics, 2003,15:171-180. 被引量:1
  • 8D'Agati V. Pathologic classification of segmental glomerulosclerosis[J]. Semin Nephrol, 2003 , 23:117-134. 被引量:1
  • 9D'Agati VD, Kaskel FJ, Falk RJ.Focal segmental glomerulosclerosis. N Engl J Med, 2011,365 (25) : 2398-2411. 被引量:1
  • 10Chun M J, Korbet SM, Schwartz MM, et al. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.J Am Soc Nephrol,2004, 15(8) :2169-2177. 被引量:1

共引文献15

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈
新型冠状病毒肺炎防控与诊疗专栏